Navigate CAR-T trial complexity: uncover key compliance, budgeting, and site readiness strategies to ensure safe, efficient, and successful patient care.
- Digital And AI As Accelerators Of Clinical Supply Strategy
- Digital Isn't The Strategy: What Actually Drives Value In Clinical Supply Transformation
- Why Lean Clinical Teams Often Create Fragile Clinical Supply Chains
- The Clinical Supply Risk In Pharma's PE Boom
- Choosing The Right Logistics Team For Complex Clinical Trials
- Scaling Security And Speed In Last-Mile Cold Chain Delivery For Clinical Trials
- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead
- The Firefighting Era Of Clinical Supply Chain Is Over. Here's What Replaces It
ON-DEMAND WEBINARS
Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.
This webinar demystifies the term “agile,” from an operational perspective, while highlighting the speed and flexibility these systems offer to be able to support complex protocols that require accelerated changes.
Gain insight into how a patient-centric approach to supply chain innovation in early phase development can accelerate your advanced therapy clinical trial programs.
Explore the opportunities to optimize your supply chain strategy and facilitate direct-to-site, direct-to-patient and hybrid services utilizing a global GMP depot network.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1221576332 cell therapy]( "Logistics In Cell Therapy: Reducing Workflow Risk")
Logistics In Cell Therapy: Reducing Workflow RiskExplore key steps that should be taken when executing a cell therapy clinical trial, from selecting the right sites to optimizing study retention.
-
![GettyImages-1070902452-planning-tracking-packaging-shipment]( "Winning The Race To FPI With Early Randomization And Trial Supply Management")
Winning The Race To FPI With Early Randomization And Trial Supply ManagementLearn why the ability to get investigational products to sites, and appropriately store them, is not a given – and this oversight can have serious consequences.
-
![GettyImages-1253545551-OSD-pill-tablet-oral-solid-dose]( "Development And Manufacture Of A Highly Potent OSD Product")
Development And Manufacture Of A Highly Potent OSD ProductHighly potent drug compounds require advanced containment and robust technical transfer protocols. CDMOs overcome challenges through meticulous testing, specialized tooling, and strong supplier relationships.
-
![GettyImages-1184502868 oncology patient]( "Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial")
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology TrialUncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
![gettyimages-871704288-170667a]( "The Patient-Centric Clinical Supply Chain For Cell And Gene Therapies")
The Patient-Centric Clinical Supply Chain For Cell And Gene TherapiesThis article explores how delivering cell and gene therapies to patients requires new levels of agility, flexibility and innovation in the logistical management of supply.
-
![Medical-Research-laborratory-GettyImages-1354172439]( "Investigational Medicinal Products: Labeling Changes And Their Implications")
Investigational Medicinal Products: Labeling Changes And Their ImplicationsLearn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.
-
![Risk-GettyImages-1364371014]( "How Long Is Your RTSM Risk Mitigation List?")
How Long Is Your RTSM Risk Mitigation List?While RTSM systems help reduce many of the risks in clinical trials, each trial’s unique setup necessitates a risk analysis to identify trial-specific challenges.
-
![GettyImages-1333159166-cold-chain-shipping-logistics-transportation]( "Transforming The Pharma Supply Chain")
Transforming The Pharma Supply ChainStart leveraging logistics partners with global end-to-end solutions that can help avoid costly delays, ensure high product quality, and accelerate impactful solutions for patients worldwide.
-
![Internet-Medical-Things-iStock-914789708]( "How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers")
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment NumbersExplore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
![pharma-spray-drying-GettyImages-1746637448]( "How CDMOs Deliver Precision and Scale in Pharma Spray Drying")
How CDMOs Deliver Precision and Scale in Pharma Spray DryingSpray drying depends on precise control, scalable methods, and solid quality systems. Strong design and GMP‑aligned execution help reduce risk and move complex compounds forward efficiently.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
